BMS Grows Its Lung Cancer Portfolio With ‘Best-In-Class’ Augtyro Approval

Drug Addresses 1%-2% Of NSCLC Patients

 
• By Mandy Jackson
  
Lungs anatomy part glowing light X-ray abstract concept vector illustration
ROS1-positive NSCLC patients tend to be younger and women • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip